Macular Degeneration - Complications
Research News and Information

Sunday, November 22, 2009

Efficacy of intravitreal bevacizumab (Avastin) therapy for early and advanced neovascular age-related macular degeneration.

15 Oct 2009 PURPOSE: To evaluate the safety and efficacy of intravitreal bevacizumab therapy for early and advanced neovascular age-related macular degeneration (ARMD). METHODS: A consecutive series of eyes with neovascular ARMD treated with monthly ... Read more...

Treatment of choroidal neovascularization associated with Best's disease in children.

20 Sep 2009 The development of secondary choroidal neovascularization in Best's disease is rare in the pediatric population. A retrospective review of pediatric patients with choroidal neovascularization secondary to Best's disease was performed. The patients' ... Read more...

One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups.

6 Sep 2009 PURPOSE: To report 1-year clinical outcomes of intravitreal ranibizumab treatment for choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) and to identify predictive factors that may influence visual acuity (VA) outcomes ... Read more...

Latest indexed articles for 'Macular Degeneration - Complications'

These are the very latest articles for this heading:

• Efficacy of intravitreal bevacizumab (Avastin) therapy for early and advanced neovascular age-related macular degeneration. 15 Oct 2009
• Treatment of choroidal neovascularization associated with Best's disease in children. 20 Sep 2009
• One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups. 6 Sep 2009
• Treatment of serous pigment epithelium detachment with subthreshold micropulse diode laser photocoagulation: a case report. 30 Aug 2009
• Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration. 30 Aug 2009
• Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27. 20 Aug 2009
• Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab. 11 Aug 2009
• Ranibizumab and nonocular hemorrhage. 30 Jul 2009
• A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. 27 Jul 2009
• Multivitamin supplements, ageing, and loss of vision: seeing through the shadows. 11 Jul 2009
• Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. 7 Jul 2009
• Patterns of referral of retinal patients for low vision intervention in the anti-VEGF era. 29 Jun 2009
• Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy. 29 Jun 2009
• Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration. 29 Jun 2009
• Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation. 29 Jun 2009
• Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. 29 Jun 2009
• Spontaneous suprachoroidal hemorrhage associated with age-related macular degeneration and anticoagulation therapy. 29 Jun 2009
• Charles Bonnet syndrome: case presentation and literature review. 29 Jun 2009
• The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system. 29 Jun 2009
• Functional aspects of drusen regression in age-related macular degeneration. 14 Jun 2009

See a longer list of these articles.

Technical information about 'Macular Degeneration'

Definition: Degenerative changes in the macula lutea of the retina.

Descriptor UI: D008268

Alternative terms: Macular Degeneration; Degeneration, Macular; Degenerations, Macular; Macular Degenerations; Age-Related Maculopathy; Age Related Maculopathy; Age-Related Maculopathies; Age Related Maculopathies; Maculopathies, Age-Related; Maculopathies, Age Related; Maculopathy, Age-Related; Maculopathy, Age Related;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C11.768.585.439;

Online Note: search RETINAL DEGENERATION 1970-74

History Note: 79(75); was see under RETINAL DEGENERATION 1970-78

Technical Notes: macular refers to macula lutea of retina; includes "macular dystrophy"